Mobilicom (NASDAQ:MOB) versus Halma (OTCMKTS:HLMAF) Head to Head Analysis

Mobilicom (NASDAQ:MOB) and Halma (OTCMKTS:HLMAF) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.

Valuation and Earnings

This table compares Mobilicom and Halma”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobilicom	$3.36 million	25.62	-$23.73 million	N/A	N/A
Halma	$2.87 billion	8.63	$378.18 million	N/A	N/A

Halma has higher revenue and earnings than Mobilicom.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mobilicom and Halma, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobilicom	1	1	2	0	2.25
Halma	1	2	2	2	2.71

Mobilicom presently has a consensus price target of $2,750.00, indicating a potential upside of 38,907.09%. Given Mobilicom’s higher possible upside, analysts clearly believe Mobilicom is more favorable than Halma.

Profitability

This table compares Mobilicom and Halma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobilicom	N/A	N/A	N/A
Halma	N/A	N/A	N/A

Institutional & Insider Ownership

13.6% of Mobilicom shares are held by institutional investors. 7.2% of Mobilicom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Mobilicom has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500. Comparatively, Halma has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500.

Summary

Mobilicom beats Halma on 5 of the 9 factors compared between the two stocks.

About Mobilicom

Mobilicom Limited operates as an end-to-end provider of cybersecurity and smart solutions for drones, robotics, and autonomous platforms. It designs, develops, and delivers smart solutions, such as cloud management software, communication datalink and mobile mesh networking terminals, handheld control terminals, and professional services and support for drone, robotics, and autonomous system manufacturers, as well as hardware products and software solutions. Mobilicom Limited was incorporated in 2017 and is based in Shoham, Israel.

About Halma

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.